151 related articles for article (PubMed ID: 18768138)
1. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.
Arora M; Kumar A; Kaundal RK; Sharma SS
Eur J Pharmacol; 2008 Oct; 596(1-3):77-83. PubMed ID: 18768138
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats.
Thiyagarajan M; Kaul CL; Sharma SS
Br J Pharmacol; 2004 Jul; 142(5):899-911. PubMed ID: 15197101
[TBL] [Abstract][Full Text] [Related]
3. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
[TBL] [Abstract][Full Text] [Related]
4. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
Negi G; Kumar A; Sharma SS
Biochem Biophys Res Commun; 2010 Jan; 391(1):102-6. PubMed ID: 19900402
[TBL] [Abstract][Full Text] [Related]
5. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.
Obrosova IG; Drel VR; Oltman CL; Mashtalir N; Tibrewala J; Groves JT; Yorek MA
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1645-55. PubMed ID: 17911342
[TBL] [Abstract][Full Text] [Related]
6. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice.
Nangle MR; Cotter MA; Cameron NE
Eur J Pharmacol; 2004 Oct; 502(1-2):143-8. PubMed ID: 15464100
[TBL] [Abstract][Full Text] [Related]
7. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
8. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sayyed SG; Kumar A; Sharma SS
Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
[TBL] [Abstract][Full Text] [Related]
9. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy.
Negi G; Kumar A; Kaundal RK; Gulati A; Sharma SS
Neuropharmacology; 2010 Mar; 58(3):585-92. PubMed ID: 20005237
[TBL] [Abstract][Full Text] [Related]
10. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats.
Lancel S; Tissier S; Mordon S; Marechal X; Depontieu F; Scherpereel A; Chopin C; Neviere R
J Am Coll Cardiol; 2004 Jun; 43(12):2348-58. PubMed ID: 15193704
[TBL] [Abstract][Full Text] [Related]
11. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.
Obrosova IG; Mabley JG; Zsengellér Z; Charniauskaya T; Abatan OI; Groves JT; Szabó C
FASEB J; 2005 Mar; 19(3):401-3. PubMed ID: 15611153
[TBL] [Abstract][Full Text] [Related]
12. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Sharma SS; Kumar A; Arora M; Kaundal RK
Free Radic Res; 2009 Apr; 43(4):400-8. PubMed ID: 19291593
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
[TBL] [Abstract][Full Text] [Related]
15. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
Kumar A; Kaundal RK; Iyer S; Sharma SS
Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
[TBL] [Abstract][Full Text] [Related]
16. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
Sharma SS; Kumar A; Kaundal RK
Life Sci; 2008 Mar; 82(11-12):570-6. PubMed ID: 18262571
[TBL] [Abstract][Full Text] [Related]
18. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
Nangle MR; Gibson TM; Cotter MA; Cameron NE
Planta Med; 2006 May; 72(6):494-500. PubMed ID: 16773532
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
Inkster ME; Cotter MA; Cameron NE
Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
[TBL] [Abstract][Full Text] [Related]
20. Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy.
Stavniichuk R; Shevalye H; Lupachyk S; Obrosov A; Groves JT; Obrosova IG; Yorek MA
Diabetes Metab Res Rev; 2014 Nov; 30(8):669-78. PubMed ID: 24687457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
